Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
217.5 USD | +0.90% | -0.66% | -6.02% |
06-10 | Added health benefits of Wegovy, Zepbound could attract more men, doctors say | RE |
06-06 | Goldman Sachs Initiates IQVIA With Buy Rating, $270 Price Target | MT |
Sales 2024 * | 15.48B 1,211B | Sales 2025 * | 16.56B 1,295B | Capitalization | 39.62B 3,099B |
---|---|---|---|---|---|
Net income 2024 * | 1.34B 104B | Net income 2025 * | 1.57B 123B | EV / Sales 2024 * | 3.32 x |
Net Debt 2024 * | 11.74B 918B | Net Debt 2025 * | 11.16B 872B | EV / Sales 2025 * | 3.07 x |
P/E ratio 2024 * |
29.7
x | P/E ratio 2025 * |
24.9
x | Employees | 87,000 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 70% |
Latest transcript on Iqvia Holdings Inc.
1 day | +0.90% | ||
1 week | -0.66% | ||
Current month | -0.74% | ||
1 month | -7.10% | ||
3 months | -16.07% | ||
6 months | +0.01% | ||
Current year | -6.02% |
Managers | Title | Age | Since |
---|---|---|---|
Ari Bousbib
CEO | Chief Executive Officer | 63 | 02/10/16 |
Ronald Bruehlman
DFI | Director of Finance/CFO | 63 | 31/07/20 |
James Berkshire
COO | Chief Operating Officer | 51 | 30/06/17 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Danhakl
BRD | Director/Board Member | 67 | 02/10/16 |
Colleen Goggins
BRD | Director/Board Member | 68 | 26/07/17 |
Ari Bousbib
CEO | Chief Executive Officer | 63 | 02/10/16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.67% | 0 M€ | 0.00% | - | |
3.45% | 0 M€ | 0.00% | - | |
2.92% | 1 M€ | +0.84% | - | |
2.68% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
12/06/24 | 217.5 | +0.90% | 1,233,606 |
11/06/24 | 215.5 | -0.15% | 1,613,709 |
10/06/24 | 215.8 | -1.55% | 1,670,182 |
07/06/24 | 219.2 | -0.57% | 1,305,265 |
06/06/24 | 220.5 | +0.73% | 1,146,698 |
Delayed Quote Nyse, June 12, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.02% | 39.62B | |
+48.54% | 56.61B | |
+37.46% | 39.25B | |
-6.90% | 28.28B | |
+12.97% | 26.44B | |
-16.91% | 20.12B | |
+31.71% | 12.48B | |
+28.18% | 12.51B | |
+0.38% | 12.2B | |
-9.54% | 11.02B |
- Stock Market
- Equities
- IQV Stock